Effects of microwave ablation on serum Golgi protein 73 in patients with primary liver cancer

doi:10.3748/wjg.v28.i29.3971

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 28, Issue 29

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4555)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-1) series.

Item

Count

PDF

192

WORD

HTML

1907

Figures (1-4)

406

Tables (1-1)

428

Sum=2994

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

419

Download

1142

Sum=1561

Aug 7, 2022 (publication date) through Feb 11, 2025

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Aug 7, 2022; 28(29): 3971-3980
Published online Aug 7, 2022. doi: 10.3748/wjg.v28.i29.3971

Table 1 Liver biochemical tests in the primary liver cancer patients before and after microwave ablation treatment

	ALB (g/L)	TBIL (μmol/L)	ALT (U/L)	AST (U/L)	GP73 (mg/L)	AFP (mg/L)
Cases	150	150	150	150	150	102¹
Before MWA	42.10 (38.83, 45.20)	16.20 (12.70, 23.35)	30.10 (20.55, 41.55)	28.30 (22.05, 35.40)	90.83 (54.49, 110.60)	110.40 (32.71, 267.30)
1 wk after MWA	38.40 (36.65, 41.15)^a	24.80(16.25, 30.60)^a	102.20(88.65, 166.30)^a	81.70(68.25, 91.30)^a	127.10(84.66, 175.50)^a	37.61(23.30, 95.48)^a
2 wk after MWA	40.30 (38.36, 42.00)	15.00 (12.90, 18.05)	29.40 (25.65, 36.85)	29.00 (24.10, 36.05)	130.70 (88.39, 163.60)	27.34 (6.32, 81.59)^b
4 wk after MWA	43.75 (37.12, 47.31)	17.35 (13.62, 25.76)	33.21 (21.57, 43.82)	26.29 (19.70, 40.61)	102.20 (59.15, 121.90)	7.32 (3.87, 16.25)^c
^at/W	7.037 (t)	3.991 (t)	6.703 (t)	5.768 (t)	5.150 (t)	-157 (W)
^aP	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001

¹Cases with significantly elevated alpha-fetoprotein.

^aP < 0.001 vs before microwave ablation (MWA) as a control.

^bP < 0.001 (W = -190) versus before MWA as a control.

^cP < 0.001 (W = -253) versus before MWA as a control.

t from the paired t-test for normally distributed data and W from the paired Wilcoxon signed-rank test for non-normally distributed data.

MWA: Microwave ablation; ALB: Serum albumin; TBIL: Total bilirubin; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; AFP: Alpha-fetoprotein; GP73: Golgi protein 73.

Citation: Xu ZJ, Wei MJ, Zhang XM, Liu HG, Wu JP, Huang JF, Li YF, Huang ZJ, Yan YY. Effects of microwave ablation on serum Golgi protein 73 in patients with primary liver cancer. World J Gastroenterol 2022; 28(29): 3971-3980
URL: https://www.wjgnet.com/1007-9327/full/v28/i29/3971.htm
DOI: https://dx.doi.org/10.3748/wjg.v28.i29.3971